Registering a Class IIa medical device with the Australian Therapeutic Goods Administration (TGA) requires fulfilling specific regulatory, technical, and procedural obligations to ensure the device's safety, quality, and performance. Below are the key requirements for registering a Class IIa device with the TGA:

1. Device Classification

• Classify the Device Correctly: Ensure that your device falls under the Class IIa category. Class IIa devices are medium-risk medical devices with moderate invasiveness or a limited level of interaction with the human body. Examples include surgical gloves, dental fillings, and contact lenses.

The classification is based on the intended use and level of risk associated with the device. The TGA’s classification rules align closely with the EU’s Medical Device Regulation (MDR).

2. Appoint an Australian Sponsor

If you are a manufacturer based outside of Australia, you must appoint an Australian sponsor. The sponsor is legally responsible for:

• Submitting the device application to the TGA.
• Ensuring compliance with all TGA regulations.
• Maintaining records and managing post-market activities.

The sponsor must be an Australian resident or entity with an established presence in Australia.

3. Conformity Assessment

Before a device can be listed in the Australian Register of Therapeutic Goods (ARTG), it must undergo a conformity assessment to verify that it meets the Essential Principles of safety and performance.

Conformity Assessment Pathways:

1. Using Overseas Certification (CE Mark):

   • If the device is already CE marked (EU Medical Device Regulation), you can use the CE certification as evidence of compliance in the TGA application. The TGA often accepts certificates from European regulatory bodies.

2. TGA Conformity Assessment:

   • For devices that do not have overseas certification, you will need a conformity assessment conducted by the TGA. This involves evaluating the manufacturer’s quality management system and technical documentation.

4. Essential Principles of Safety and Performance

The device must comply with the Essential Principles outlined by the TGA, which are similar to international standards. These include:

• Design and Manufacturing: The device must be designed and manufactured to meet safety and performance standards.
• Risk Management: A risk analysis, in accordance with ISO 14971, must be conducted to ensure that all potential hazards are identified and mitigated.
• Clinical Evidence: Provide evidence demonstrating the clinical safety and performance of the device based on clinical data, trials, or literature.
• Labeling and Instructions for Use (IFU): The device must be appropriately labeled with clear instructions on its use, warnings, and contraindications.

5. Technical Documentation

Comprehensive technical documentation is required to demonstrate that the device meets regulatory standards. The required documentation includes:

• Device Description: Detailed information about the device, its intended purpose, and how it works.
• Risk Management File: Evidence that risk assessments have been performed, including any identified risks and mitigations.
• Clinical Data: Clinical evaluation reports or data supporting the device's safety and performance.
• Verification and Validation Data: Test results proving that the device meets performance specifications and regulatory requirements.
• Labeling and Instructions for Use: Details on the device’s labeling, packaging, and user instructions.

6. Submit the Application via TGA Business Services Portal

The application for listing the device on the Australian Register of Therapeutic Goods (ARTG) must be submitted through the TGA Business Services (TBS) portal by the Australian sponsor. The submission includes:

• Manufacturer’s Evidence: Documentation such as CE certificates or TGA-issued conformity assessment certificates.
• Device Information: Including the Global Medical Device Nomenclature (GMDN) code, device classification, and intended use.
• Labeling and Packaging: Details on product labeling, instructions for use, and any relevant packaging information.

7. Fees

The TGA charges fees for both the application and, where required, the evaluation process. The fees include:

• Application Fee: For submitting the device to the ARTG.
• Evaluation Fee (if applicable): If the TGA needs to conduct an in-depth evaluation of the device or conformity assessment documentation.

Fee amounts depend on the type of device and the complexity of the evaluation. The latest fee schedule is available on the TGA’s website.

8. TGA Review and Assessment

The TGA will review the submitted application and assess the conformity assessment documents, technical file, and clinical evidence to ensure the device meets Australian regulations.

If the device is CE marked, the review process is often expedited, as the TGA recognizes conformity assessments from equivalent international regulatory authorities.

9. Inclusion in the ARTG

Once the application is approved, the device will be included in the Australian Register of Therapeutic Goods (ARTG). The sponsor will receive an ARTG certificate, confirming that the device is approved for legal supply in Australia.

10. Post-Market Obligations

After ARTG inclusion, the sponsor is responsible for ensuring ongoing compliance with post-market regulations. These obligations include:

• Monitoring Adverse Events: Report adverse events, device malfunctions, or product recalls to the TGA.
• Post-Market Surveillance: Ongoing collection of data regarding the device’s performance in the field.
• Changes to the Device: Any significant changes to the device’s design, manufacturing process, or labeling must be reported to the TGA.
• Regular Record Keeping: Maintain up-to-date records of the device’s technical documentation and risk management activities for potential audits.

Summary of Key Requirements:

1. Device Classification: Confirm the device is Class IIa.
2. Appoint an Australian Sponsor: Mandatory if the manufacturer is overseas.
3. Conformity Assessment: Complete the conformity assessment using overseas certification or TGA’s own review process.
4. Essential Principles Compliance: Ensure the device meets the safety and performance requirements.
5. Technical Documentation: Submit detailed technical documents, including clinical evidence, risk management, labeling, and design data.
6. Application Submission: Submit the application via the TGA Business Services portal.
7. Pay the Fees: Application and evaluation fees must be paid as required.
8. TGA Review: The TGA will review the submission for ARTG inclusion.
9. ARTG Listing: Upon approval, the device will be included in the ARTG.
10. Post-Market Compliance: Follow post-market obligations, including adverse event reporting and surveillance.

Following these requirements ensures that the device complies with Australian medical device regulations and can be legally marketed or supplied in the country.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn